Insider Transactions in Q3 2025 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 07
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-3.65%
|
$3,300,000
$300.57 P/Share
|
|
Aug 07
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,485,000
$135.42 P/Share
|
|
Jul 25
2025
|
Louis W Sullivan |
BUY
Exercise of conversion of derivative security
|
Indirect |
590
+50.0%
|
-
|
|
Jul 25
2025
|
Richard Giltner |
BUY
Exercise of conversion of derivative security
|
Direct |
1,190
+5.47%
|
-
|
|
Jul 25
2025
|
Ray Kurzweil |
BUY
Exercise of conversion of derivative security
|
Direct |
590
+4.45%
|
-
|
|
Jul 25
2025
|
Nilda Mesa |
BUY
Exercise of conversion of derivative security
|
Direct |
590
+9.73%
|
-
|
|
Jul 25
2025
|
Judy D. Olian |
BUY
Exercise of conversion of derivative security
|
Direct |
1,190
+14.81%
|
-
|
|
Jul 25
2025
|
Christopher Patusky |
BUY
Exercise of conversion of derivative security
|
Direct |
590
+28.37%
|
-
|
|
Jul 25
2025
|
Jan Malcolm |
BUY
Exercise of conversion of derivative security
|
Direct |
590
+32.6%
|
-
|
|
Jul 25
2025
|
Christopher Causey |
BUY
Exercise of conversion of derivative security
|
Direct |
1,190
+19.65%
|
-
|
|
Jul 24
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-8.32%
|
$3,344,000
$304.23 P/Share
|
|
Jul 24
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,485,000
$135.42 P/Share
|
|
Jul 10
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
11,000
-6.11%
|
$3,289,000
$299.77 P/Share
|
|
Jul 10
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+18.71%
|
$1,485,000
$135.42 P/Share
|